Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2-Reference-Cited by-同舟云学术

Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2

Published:2011-08-17 Issue:1 Volume:11 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Mohamedali Khalid A,Ran Sophia,Gomez-Manzano Candelaria,Ramdas Latha,Xu Jing,Kim Sehoon,Cheung Lawrence H,Hittelman Walter N,Zhang Wei,Waltenberger Johannes,Thorpe Philip E,Rosenblum Michael G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-11-358.pdf

Reference38 articles.

1. Siemann DW, Horsman MR: Vascular targeted therapies in oncology. Cell Tissue Res. 2009, 335: 241-248. 10.1007/s00441-008-0646-0.

2. Bernatchez PN, Rollin S, Soker S, Sirois MG: Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. J Cell Biochem. 2002, 85: 629-639. 10.1002/jcb.10155.

3. Han YS, Lee JE, Jung JW, Lee JS: Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2009, 247: 541-548. 10.1007/s00417-008-0976-3.

4. Karamysheva AF: Mechanisms of angiogenesis. Biochemistry (Mosc). 2008, 73: 751-762. 10.1134/S0006297908070031.

5. Pourgholami MH, Morris DL: Inhibitors of vascular endothelial growth factor in cancer. Cardiovasc Hematol Agents Med Chem. 2008, 6: 343-347. 10.2174/187152508785909528.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Light-enhanced VEGF121/rGel induce immunogenic cell death and increase the antitumor activity of αCTLA4 treatment;Frontiers in Immunology;2023-12-19

2. In Vitro and In Vivo Studies of a Heminecrolysin Toxin–VEGF Fusion Protein as a Novel Therapeutic for Solid Tumor Targeting;Molecular Biotechnology;2022-10-06

3. Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy;Journal of Controlled Release;2018-10

4. Targeting of Tumor Neovasculature with GrB/VEGF121, a Novel Cytotoxic Fusion Protein;Biomedicines;2017-07-17

5. Ponatinib reduces viability, migration, and functionality of human endothelial cells;Leukemia & Lymphoma;2016-10-12